Development and Evaluation of Polyherbal Based Novel Antiaging Synergistic Formulation

Aim: The present work was aimed to develop and evaluate polyherbal-based novel antiaging formulation.

Place and Duration of Study: Faculty of pharmacy, B N University Udaipur, Department of Pharmacognosy, Divine College of pharmacy Satana between Feb 2019 to Apr 2021.

Methods: The selected plant extract Moringa oleifera hydroalcoholic extract (2%), Juglans regia aqueous extract (1%), Vitis vinifera ethanolic extract (1.5%), Camellia sinensis cold water extract (1.8%), Punica granatum aqueous extract (2%) were optimized in o/w type herbal cream by incorporation of different concentration of stearic acid and Tween 60. The total 9 formulations were evaluated on the basis of preliminary, phytochemical screening, and accelerated stability study and confirm the C7 polyherbal formulation (PHF) were more stable, safe, and showed pseudo plastic flow.

Results: The In-vitro free radical scavenging assay (DPPH Assay - IC50 56 ± 0.04 µg/ml and H2O2 scavenging assay - IC50 = 67±0.68 µg/ml) compared with standard Ascorbic acid and In-vitro anti-collagenase and anti-elastase activity validate PHF as antioxidant and antiaging activity. The in vitro Anti-collagenase activity showed 89.5% inhibition at 100 μg/mL concentration of C7 formulation (IC50 = 54.62 μg/mL) and the standard Gallic acid showed 74.6% inhibition at 100 μg/mL (IC50 = 67.83 μg/mL). The in vitro Anti-elastase activity showed 67.5% inhibition at 250 μg/mL of C7 formulation (IC50 = 193.65 μg/mL) and copper sulphate solution used as standard showed 70.6% inhibition (IC50 = 772.42 μg/mL). The percent inhibition activity was observed that the C7 formulation is potential antiaging activity as compared to positive control.

Conclusion: These studies conclude that the composition of PHF with a cream base increases the production of collagen and elastin which is responsible for the noteworthy synergistic antiaging activity.